Literature DB >> 32386410

Concomitant carriage of KPC-producing and non-KPC-producing Klebsiella pneumoniae ST512 within a single patient.

Agnès B Jousset1,2,3,4, Rémy A Bonnin1,3,4, Julie Takissian1, Delphine Girlich1,4, Liliana Mihaila2, Nicolas Cabanel4, Laurent Dortet1,2,3,4, Philippe Glaser4,5, Thierry Naas1,2,3,4.   

Abstract

BACKGROUND: KPC-producing Klebsiella pneumoniae of clonal group 258 are prominent in healthcare settings in many regions of the world. The blaKPC gene is mostly carried by a multireplicon IncFIIk-IncFI plasmid suspected to be highly compatible and stable in this genetic background. Here, we analysed the genetic diversity of an ST512 K. pneumoniae population in a single patient.
METHODS: Twelve K. pneumoniae isolates (n = 5 from urine samples and n = 7 from rectal swabs) were recovered from one patient over a 2 month period. Antimicrobial susceptibility testing, plasmid extraction and WGS were performed on all isolates. The first K. pneumoniae isolate, D1, was used as a reference for phylogenetic analysis.
RESULTS: Antimicrobial susceptibility testing, plasmid analysis and WGS revealed concomitant carriage of carbapenem-resistant and carbapenem-susceptible K. pneumoniae isolates of ST512, with the absence of the entire blaKPC-carrying plasmid in the susceptible population. Furthermore, 14 other genetic events occurred within the genome, including 3 chromosomal deletions (of 71 kb, 33 kb and 11 bp), 2 different insertions of ISKpn26 and 9 SNPs. Interestingly, most of the events occurred in the same chromosomal region that has been deleted independently several times, probably after homologous recombination involving 259 bp repeated sequences.
CONCLUSIONS: Our study revealed (to the best of our knowledge) the first case of in vivo blaKPC-carrying plasmid curing and a wide within-patient genetic diversity of a single K. pneumoniae ST512 clone over a short period of carriage. This within-patient diversity must be taken into account when characterizing transmission chains using WGS during nosocomial outbreaks.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32386410     DOI: 10.1093/jac/dkaa137

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  In-Human Multiyear Evolution of Carbapenem-Resistant Klebsiella pneumoniae Causing Chronic Colonization and Intermittent Urinary Tract Infections: A Case Study.

Authors:  Michelle Kalu; Karen Tan; Marquerita Algorri; Peter Jorth; Annie Wong-Beringer
Journal:  mSphere       Date:  2022-05-09       Impact factor: 5.029

2.  Bordetella hinzii Pneumonia in Patient with SARS-CoV-2 Infection.

Authors:  Hend Ben Lakhal; José Bras Cachinho; Pierre Kalfon; Thierry Naas; Zehaira Benseddik
Journal:  Emerg Infect Dis       Date:  2022-04       Impact factor: 6.883

Review 3.  The importance of antimicrobial resistance in medical mycology.

Authors:  Neil A R Gow; Carolyn Johnson; Judith Berman; Alix T Coste; Christina A Cuomo; David S Perlin; Tihana Bicanic; Thomas S Harrison; Nathan Wiederhold; Mike Bromley; Tom Chiller; Keegan Edgar
Journal:  Nat Commun       Date:  2022-09-12       Impact factor: 17.694

4.  Prevalence of blaKPC-2, blaKPC-3 and blaKPC-30-Carrying Plasmids in Klebsiella pneumoniae Isolated in a Brazilian Hospital.

Authors:  Letícia B Migliorini; Romário O de Sales; Paula C M Koga; Andre M Doi; Anja Poehlein; Alexandra R Toniolo; Fernando G Menezes; Marines D V Martino; Ana C Gales; Holger Brüggemann; Patricia Severino
Journal:  Pathogens       Date:  2021-03-12

5.  Within patient genetic diversity of blaKPC harboring Klebsiella pneumoniae in a Colombian hospital and identification of a new NTEKPC platform.

Authors:  Deisy Abril; Erika Vergara; Diana Palacios; Aura Lucía Leal; Ricaurte Alejandro Marquez-Ortiz; Johana Madroñero; Zayda Lorena Corredor Rozo; Zandra De La Rosa; Carlos A Nieto; Natasha Vanegas; Jorge A Cortés; Javier Escobar-Perez
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.